Immunology/Autoimmune
- Ref-No.Technology
- 01-00937Empowering T and NK cells for adoptive cell transfer (ACT) through engineering with PD-1:4-1BB
- 02-00330Mouse models for liver immunity and therapeutic vaccinations
- 03-00207bNovel Peptide Drug enhancing Immune Response in Patients suffering from Immune Suppression and Leukopenia
- 03-00245Intracellular Target for Systemic Lupus Erythematodes (SLE)
- 03-00291Multiple Target T Cell Receptor
- 03-00380Negative regulation of the IKK/NF-kB pathway activity by stabilisation of A20 mRNA – a new approach to treat inflammation
- 03-00397Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
- 03-00399/32-00019Human satellite cells as cell therapy for the treatment of muscle waisting disorders
- 03-00417Novel BCMA-CAR for the treatment of multiple myeloma and non-Hodgkin lymphoma (NHL)
- 14-00097Anti-inflammatory, anti-bacterial agent for treatment of Atopic Dermatitis
- 14-00097Antimicrobial, endotoxine-neutralizing and anti-inflammatory agent for wound healing and treatment of bacterial skin and soft-tissue infections
- 15-00150Semaphorin 5A as potential biomarker for graft vs. host disease
- 15-00171Prediction and therapy control of large vessel vasculitis
- 15-00379Mutation leading to Type 1 Diabetes mellitus and corresponding animal model
- 15-00461Novel treatment for septic diseases in newborns
- 15-00523Novel Diagnostic for Hepatitis
- 22-00009Quiescent B Cells for immune suppression in gene therapy
- 22-00017Functional IFN-gamma memory in CD4+ T cells: Method for improved T cell therapy and disease monitoring in autoimmune diseases
- 22-00020Bispecific antibodies for cell-type-specific TNF inhibition
- 23-00069NMDAR targeted CAAR-T cell therapy
- 32-00049Preventing Vascular Calcification in Chronic Kidney Disease
- 42-00022Stabilized minigastrin analogs for enhanced CCK2R targeting and applications in neuroendocrine tumor therapeutics and diagnostics
